300
Participants
Start Date
June 21, 2023
Primary Completion Date
November 30, 2026
Study Completion Date
April 30, 2027
Encapsulated FMT
Encapsulated Faecal Microbiota Transplant
Placebo
The placebo product contains microcrystalline methylcellulose. It is supplied as a size 0, Swedish Orange Delayed-Release capsule (DRCap) and provides a complete match with regards to the appearance (e.g., dimensions, colour) to the FMT capsules.
NOT_YET_RECRUITING
Royal Bournemouth Hospital, Bournemouth
RECRUITING
Southmead Hospital, Bristol
RECRUITING
Bristol Royal Infirmary, Bristol
RECRUITING
Royal Derby Hospital, Derby
RECRUITING
Ninewells Hospital, Dundee
RECRUITING
Queen Elizabeth Hospital, Gateshead
RECRUITING
Queen Elizabeth University Hospital, Glasgow
RECRUITING
Hull Royal Infirmary, Hull
RECRUITING
St. James University Hospital, Leeds
RECRUITING
King's College Hospital NHS Foundation Trust, London
RECRUITING
St. George's University Hospital NHS Foundation Trust, London
RECRUITING
St. Mary's Hospital, London
RECRUITING
Freeman Hospital, Newcastle upon Tyne
RECRUITING
Royal Gwent Hospital, Newport
RECRUITING
Queen's Medical Centre, Nottingham
RECRUITING
Derriford Hospital, Plymouth
St George's, University of London
OTHER
Guy's and St Thomas' NHS Foundation Trust
OTHER
Imperial College London
OTHER
King's College Hospital NHS Trust
OTHER
BRITISH LIVER TRUST
UNKNOWN
King's College London
OTHER